MRK vs BSX
By Alex · Tickerpine
Merck & Co., Inc. vs Boston Scientific Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | BSX |
|---|---|---|
| Price | $145.27 | $45.69 |
| Market cap | $358.41B | $66.22B |
| P/E ratio | 117.2 | 18.5 |
| ROE | 6.96% | 15.34% |
| Profit margin | 4.77% | 17.50% |
| Revenue growth | 5.10% | 7.50% |
| Dividend yield | 2.34% | 0.00% |
| Beta | 0.22 | 0.57 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs BSX in plain English
- MRK is the bigger company — about 5.4× the market cap of BSX.
- BSX is cheaper on earnings (P/E 18.5 vs 117.2).
- BSX earns a higher return on equity (15% vs 7%).
- BSX is growing revenue faster (8% vs 5%).
- MRK pays a dividend (2.34%) while the other effectively doesn't.
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
BSX return calculator
See what $1,000 in Boston Scientific Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.